Mira Pharmaceuticals (MIRA) Free Cash Flow (2022 - 2025)

Mira Pharmaceuticals has disclosed Free Cash Flow across 4 years of filings, most recently posting -$1.2 million for Q4 2025.

• Free Cash Flow for Q4 2025 came in at -$1.2 million, up 34.99% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.7 million (up 15.48% YoY), and the FY2025 annual result was -$4.7 million, up 15.48% from the prior year.
• Free Cash Flow came in at -$1.2 million for Q4 2025 at Mira Pharmaceuticals, down from -$1.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$660813.0 in Q2 2023 to a low of -$1.8 million in Q3 2024.
• The 4-year median for Free Cash Flow is -$1.1 million (2023), against an average of -$1.2 million.
• Across the five-year window, Free Cash Flow plunged 74.4% in 2024 and jumped 38.84% in 2025, its largest moves.
• Mira Pharmaceuticals' Free Cash Flow stood at -$975436.0 in 2022, then retreated by 6.11% to -$1.0 million in 2023, then slumped by 74.4% to -$1.8 million in 2024, then soared by 34.99% to -$1.2 million in 2025.
• The last three Free Cash Flow figures came in at -$1.2 million (Q4 2025), -$1.1 million (Q3 2025), and -$800000.0 (Q2 2025), per Business Quant data.